CurrentRheuma
Get Weekly

Topic · page 15 of 26

Spondyloarthritis & psoriatic arthritis

Axial spondyloarthritis (radiographic and non-radiographic), peripheral spondyloarthritis, psoriatic arthritis and psoriatic disease studied across joints and skin, enthesitis and dactylitis, arthritis with inflammatory bowel disease, reactive arthritis, uveitis in spondyloarthritis, imaging of the sacroiliac joints and spine

Briefs 561–600 of 1,039 placed here, newest publication first

Briefs in Spondyloarthritis & psoriatic arthritis

Newest publication first

  1. Rheumatology (Oxford)

    Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

    Cohort study

  2. Rheumatology (Oxford)

    Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial

    Randomized controlled trial

  3. Rheumatology (Oxford)

    HLA-B5 prevalence in patients with spondyloarthritis and impact on disease phenotype: a multicentric case–control study

    Case-control study

  4. Arthritis Care Res (Hoboken)

    Prevalence of Fibromyalgia and Widespread Pain in Psoriatic Arthritis: Association With Disease Severity Assessment in a Large US Registry

    Cross-sectional study

  5. J Rheumatol

    Using Ultrasound to Improve Diagnostic Confidence and Management of Psoriatic Disease: Highlights From the GRAPPA 2023 Ultrasound Workshop

    Research article

  6. J Rheumatol

    GRAPPA 2023 Annual Meeting Report: Hot Topic Session on Measurement of Musculoskeletal Symptoms in Psoriatic Disease

    Research article

  7. J Rheumatol

    Advancing Basic and Translational Science: Highlights From the Basic Science Workshop at the GRAPPA 2023 Annual Meeting

    Research article

  8. J Rheumatol

    Difficult-to-Treat Concept in Psoriatic Arthritis: Analysis of 2 Potential Definitions in a Large Group of Patients. A Cross-Sectional Study

    Cross-sectional study

  9. J Rheumatol

    Biomarkers in Psoriasis and Psoriatic Arthritis: Where Are We Now?

    Research article

  10. Ann Rheum Dis

    Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis

    Cohort study

  11. Ann Rheum Dis

    Validation and incorporation of digital entheses into a preliminary GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis

    Guideline or statement

  12. RMD Open

    Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis

    Secondary analysis

  13. Arthritis Rheumatol

    Long‐Term Follow‐Up of Anti‐Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering

    Cohort study

  14. Arthritis Care Res (Hoboken)

    When Usual Care Is Not So Usual: Protocol Violations and Generalizability in a Treat‐to‐Target Strategy Trial in Patients With Axial Spondyloarthritis

    Secondary analysis

  15. Semin Arthritis Rheum

    Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis

    Cohort study

  16. Arthritis Rheumatol

    Unveiling Metabolic Similarities of Entheses in Patients with Psoriasis and Psoriatic Arthritis Using Noninvasive In Vivo Molecular Imaging: Results From a Cross‐sectional Exploratory Study

    Cross-sectional study

  17. J Rheumatol

    Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis

    Guideline or statement

  18. Arthritis Rheumatol

    Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses

    Secondary analysis

  19. RMD Open

    Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients

    Cohort study

  20. Rheumatology (Oxford)

    Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after 2 years?

    Cohort study

  21. Lancet Rheumatol

    Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

    Randomized controlled trial

  22. Scand J Rheumatol

    Impact of pregnancy on sacroiliac imaging in women with axial spondyloarthritis: results of the analysis of the DESIR cohort

    Cohort study

  23. J Rheumatol

    Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study

    Diagnostic or prognostic study

  24. RMD Open

    Factors Associated with Poor Mental Health in Patients with Axial Spondyloarthritis: Results from the International Map of Axial Spondyloarthritis (IMAS)

    Cross-sectional study

  25. Ann Rheum Dis

    Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study

    Cross-sectional study

  26. Ann Rheum Dis

    Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort

    Cohort study

  27. RMD Open

    Anatomical pattern of entheseal and synovial fibroblast activation in patients with psoriasis and its risk of developing psoriatic arthritis

    Cohort study

  28. RMD Open

    Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis

    Cohort study

  29. RMD Open

    International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe

    Cross-sectional study

  30. Rheumatology (Oxford)

    One-year effectiveness of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations

    Randomized controlled trial

  31. RMD Open

    Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies

    Secondary analysis

  32. Scand J Rheumatol

    Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry

    Cohort study

  33. Scand J Rheumatol

    Efficacy and safety of iguratimod combined with celecoxib in active axial spondyloarthritis: a randomized, double-blind, placebo-controlled study

    Randomized controlled trial

  34. Arthritis Res Ther

    Exploration of the combined role of immune checkpoints and immune cells in the diagnosis and treatment of ankylosing spondylitis: a preliminary study immune checkpoints in ankylosing spondylitis

    Mechanistic study

  35. Rheumatology (Oxford)

    Association of ankylosing spondylitis with the risk of cancer: a meta-analysis of cohort studies

    Meta-analysis

  36. Semin Arthritis Rheum

    Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study

    Cohort study

  37. Semin Arthritis Rheum

    The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis

    Cohort study

  38. J Rheumatol

    Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials

    Secondary analysis

  39. Arthritis Care Res (Hoboken)

    Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway

    Cohort study

  40. Arthritis Res Ther

    Investigating protease-mediated peptides of inflammation and tissue remodeling as biomarkers associated with flares in psoriatic arthritis

    Case-control study

All 1,039 Briefs in ExploreShowing Briefs 561–600 of 1,039, newest first